Table of Contents Table of Contents
Previous Page  524 692 Next Page
Information
Show Menu
Previous Page 524 692 Next Page
Page Background

Table 1 (

Continued

)

Author, yr of

publication

Population

investigated

Recruitment

criteria

No. of

patients

Mean

age (yr)

Mean PSA

(ng/ml)

MRI used; magnet

strength

Coil used

(no. channels)

Threshold for target

biopsy

Biopsy method;

approach

SB and

TB cores

Definition of clinically

significant PCa

Thompson

et al., 2014

[20]

Negative or no

prior biopsy

Elevated PSA and/or

abnormal DRE

150 62.0

5.6 Unknown; 1.5 and

3.0 Tesla

PPA (32)

PIRADS 3 or higher Cognitive TRUS and

MRI/TRUS fusion;

transperineal

Yes Multiple definitions; applied

definition:

-Gleason score 3 + 4 and

>

5% grade 4 component and

<

50% cores positive

-or Gleason score 3 + 3 and

<

5% grade 4 component and

<

30% cores positive

-or MCCL 8 mm

Pokorny

et al., 2014

[23]

No prior biopsy Elevated PSA and/or

abnormal DRE

142 63.0

5.3 Magnetom Skyra

(Siemens); 3 Tesla

PPA

PIRADS 3 or higher In-bore MRI; transrectal

Yes -Gleason score = 3 + 3 and

MCCL 6 mm

-or Gleason score = 3 + 4 and

MCCL 4 mm

-or Gleason score 4 + 3

Jambor et al.,

[10_TD$DIFF]

2015

[74]

No prior biopsy Elevated PSA

53 66.0

7.4 Magnetom Verio

(Siemens); 3 Tesla

PPA

PIRADS 4 or higher Cognitive TRUS;

transrectal

Yes -Gleason score 3 + 4

-or Gleason score = 3 + 3 and

MCCL 3 mm

Boesen et al.,

[10_TD$DIFF]

2015

[75]

Negative prior

biopsy

Elevated PSA and/or

abnormal DRE

83 63.0

11.0 Achieva (Philips);

3 Tesla

PPA (6)

No threshold

defined

Cognitive TRUS;

transrectal

Yes Epstein criteria

Habchi et al., 2014

[14_TD$DIFF]

[76]

Mixed

population

Elevated PSA and/or

abnormal DRE

204 61.8

8.3 Discovery (GE); 3 Tesla PPA

PIRADS 2 or higher Cognitive TRUS;

transrectal

Yes Gleason score 3 + 4

Sonn et al., 2014

[11_TD$DIFF]

[77]

Negative prior

biopsy

Elevated PSA

105 65.0

7.5 Trio Tim (Siemens);

3 Tesla

PPA

PIRADS 2 or higher MRI/TRUS fusion;

transrectal

Yes -Gleason score 3 + 4

-or Gleason score = 3 + 3 and

MCCL 4 mm

Quentin et al., 2014

[13_TD$DIFF]

[47]

N

o prior biopsy Elevated PSA

128 66.1

6.7 Magnetom Trio

(Siemens); 3 Tesla

PPA (6)

No threshold

defined

In-bore MRI; transrectal

Yes -Gleason score 3 + 4

-or Gleason score = 3 + 3 and

TCCL

>

5 mm

Pepe et al., 2015

[15_TD$DIFF]

[78]

Negative prior

biopsy

Elevated PSA

100 64.0

8.6 Achieva (Philips);

3 Tesla

PPA (16)

PIRADS 4 or higher Cognitive TRUS;

transperineal

Yes -Gleason score 3 + 4

-or Gleason score = 3 + 3 and

TCCL

>

50%

DRE = digital rectal examination; ERC = Endorectal coil; MMCL = maximum cancer core length; MRI = magnetic resonance imaging; PCa = prostate cancer; PIRADS = prostate imaging reporting and data system; PPA = Pelvic

Phased Array; PSA = prostate-specific antigen; SB = systematic biopsy; TB = target biopsy; TCCL = total cancer core length; TRUS = transrectal ultrasound.

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 5 1 7 – 5 3 1

524